---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-010083"
form_type: "8-K"
ticker: "NMTC"
cik: "0001500198"
company_name: "NEUROONE MEDICAL TECHNOLOGIES Corp"
filed_at: "2025-02-04T23:59:59+00:00"
generated_at: "2026-05-27T03:25:24.038041+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# NeuroOne regains Nasdaq compliance; reports record preliminary Q1 revenue of $6.2M

## Summary
- Received Nasdaq letter on Feb 3, 2025 confirming cure of bid price deficiency; hearing cancelled.
- Preliminary unaudited Q1 FY2025 total revenue of $6.2M (product $3.2M + one-time license $3.0M).
- CEO highlights OneRF Ablation System as first FDA-cleared device for RF ablation in the brain.
- Earnings call scheduled for February 12, 2025 at 8:30 am ET.

## SEC filing metadata
- accession: 0001213900-25-010083
- form_type: 8-K
- ticker: NMTC
- cik: 0001500198
- company_name: NEUROONE MEDICAL TECHNOLOGIES Corp
- filed_at: 2025-02-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1500198/000121390025010083/0001213900-25-010083-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1500198/000121390025010083/ea0229869-8k_neuroone.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-010083
- JSON: https://secwatch.observer/filing/0001213900-25-010083.json
- Plain text: https://secwatch.observer/filing/0001213900-25-010083.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.